Evidence map›Paper›PMID 39351900›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players.

Annalise E Miner, Jenna R Groh, Yorghos Tripodis, Charles H Adler, Laura J Balcer, Charles Bernick, Henrik Zetterberg, Kaj Blennow, Elaine Peskind, Nicholas J Ashton and 17 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Molecular neurodegeneration · 2025
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Annalise E MinerBoston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.ORCID 0000-0002-9336-2419
Jenna R GrohBoston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Yorghos TripodisBoston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Charles H AdlerDepartment of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Laura J BalcerDepartments of Neurology, Population Health and Ophthalmology, NYU Grossman School of Medicine, New York, New York, USA.
Charles BernickCleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada, USA.
Henrik ZetterbergDepartment of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK.
Kaj BlennowClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Elaine PeskindVeterans Affairs Northwest Mental Illness Research, Education, and Clinical Center, Seattle, Washington, USA.
Nicholas J AshtonClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Charles E GaudetPhysical Medicine & Rehabilitation Service, VA Boston Healthcare System, Boston, Massachusetts, USA.
Brett MartinBiostatistics and Epidemiology Data Analytics Center (BEDAC), Boston University School of Public Health, Boston, Massachusetts, USA.
Joseph N PalmisanoBiostatistics and Epidemiology Data Analytics Center (BEDAC), Boston University School of Public Health, Boston, Massachusetts, USA.
Sarah J BanksDepartments of Neuroscience and Psychiatry, University of California, San Diego, California, USA.
William B BarrDepartment of Neurology, NYU Grossman School of Medicine, New York City, New York, USA.
Jennifer V WetheDepartment of Psychiatry and Psychology, Mayo Clinic School of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Robert C CantuBoston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
David W DodickDepartment of Neurology, Mayo Clinic College of Medicine, Mayo Clinic Arizona, Scottsdale, Arizona, USA.
Douglas I KatzDepartment of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Jesse MezBoston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Suzan van AmerongenAlzheimer Center Amsterdam, Neurology, Vrije Universiteit Amsterdam, Amsterdam UMC location VUmc, Amsterdam, The Netherlands.
Jeffrey L CummingsChambers-Grundy Center for Transformative Neuroscience, Department of Brain Health, School of Integrated Health Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, USA.
Martha E ShentonPsychiatry Neuroimaging Laboratory, Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Eric M ReimanBanner Alzheimer's Institute, University of Arizona, Arizona State University, Translational Genomics Research Institute, and Arizona Alzheimer's Consortium, Phoenix, Arizona, USA.
Robert A SternBoston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
Michael L AloscoBoston University CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.
DIAGNOSE CTE Research Project

Funding

Research Education ComponentP30AG072980 · NIA · BANNER HEALTH · PI ALIREZA ATRI · 2021 to 2026
$24.9M
Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk FactorsU01NS093334 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CUMMINGS, JEFFREY L., REIMAN, ERIC MICHAEL · 2016 to 2022
$17.0M
Risk and Resilience, Clinical presentation, and Biomarker Profiles of Chronic Traumatic Encephalopathy and Related Dementias: The DIAGNOSE CTE Research Project IIR01NS139383 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI Michael Alosco, Nicholas Ashton · 2024 to 2026
$9.3M
Blood Biomarker Development and Validation in Chronic Traumatic Encephalopathy and Alzheimer's Disease and Alzheimer's Disease Related DementiasRF1NS132290 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALOSCO, MICHAEL, STEIN, THOR · 2023 to 2023
$1.9M
AD Strategic Fund and the Alzheimer's Association ADSF-21-831376-CAD Strategic Fund and the Alzheimer's Association ADSF-21-831377-CAD Strategic Fund and the Alzheimer's Association ADSF-21-831381-CAD Strategic Fund and the Alzheimer's Association ADSF-24-1284328-CAlzheimer Drug Discovery Foundation 201809-2016862Alzheimer's Association 2021 Zenith Award ZEN-21-848495Alzheimer's Association 2022-2025 Grant SG-23-1038904 QCBluefield Project, Cure Alzheimer's FundEuropean Union Joint Program for Neurodegenerative Disorders JPND2019-466-236European Union Joint Programme-Neurodegenerative Disease Research JPND2021-00694European Union's Horizon 2020European Union's Horizon Europe 101053962Hjärnfonden, Sweden ALFGBG-715986Hjärnfonden, Sweden ALFGBG-965240Hjärnfonden, Sweden ALZ2022-0006Hjärnfonden, Sweden FO2017-0243Kirsten and Freddy Johansen Foundation, Copenhagen, DenmarkLa Fondation Recherche AlzheimerNational Institute for Health and Care Research University College London Hospitals Biomedical Research CentreNational Institute of Neurological Disorders and Stroke/National Institute on Aging RF1NS132290National Institute of Neurological Disorders and Stroke (NINDS) U01NS093334NIA NIH HHS P30 AG072980NINDS NIH HHS R01 NS139383NINDS NIH HHS RF1 NS132290NINDS NIH HHS U01 NS093334Olav Thon Foundation, the Erling-Persson Family FoundationStiftelsen för Gamla Tjänarinnor, Hjärnfonden, Sweden FO2022-0270Swedish Alzheimer Foundation AF-930351Swedish Alzheimer Foundation AF-939721Swedish Alzheimer Foundation AF-968270Swedish Alzheimer Foundation AF-994551Swedish State Support for Clinical Research #ALFGBG-71320UK Dementia Research Institute at UCL 2017-00915UK Dementia Research Institute at UCL 2022-00732UK Dementia Research Institute at UCL UKDRI-1003
6 · The paper itself

Abstract

introductionBlood-based biomarkers offer a promising approach for the detection of neuropathologies from repetitive head impacts (RHI). We evaluated plasma biomarkers of amyloid, tau, neurodegeneration, and inflammation in former football players.

methodsThe sample included 180 former football players and 60 asymptomatic, unexposed male participants (aged 45-74). Plasma assays were conducted for beta-amyloid (Aβ) 40, Aβ42, hyper-phosphorylated tau (p-tau) 181+231, total tau (t-tau), neurofilament light (NfL), glial fibrillary acidic protein (GFAP), interleukin-6 (IL-6), Aβ42/p-tau181 and Aβ42/Aβ40 ratios. We evaluated their ability to differentiate the groups and associations with RHI proxies and traumatic encephalopathy syndrome (TES).

resultsP-tau181 and p-tau231(p DISCUSSION: Plasma p-tau181 and p-tau231, GFAP, and NfL may offer some usefulness for the characterization of RHI-related neuropathologies. HIGHLIGHTS: Former football players had higher plasma p-tau181 and p-tau231 and lower Aβ42/ptau-181 compared to asymptomatic, unexposed men. Younger age of first exposure was associated with increased plasma NfL and GFAP in older but not younger participants. Plasma GFAP was higher in participants with TES-CTE possible/probable compared to TES-CTE no/suggestive.

Indexed as

Amyloid beta-PeptidesBiomarkersFootballtau ProteinsAgedAthletesGlial Fibrillary Acidic ProteinHumansInterleukin-6MaleMiddle AgedNeurofilament ProteinsNeuroinflammatory DiseasesPeptide FragmentsUnited StatesAmyloid beta-PeptidesBiomarkersGFAP protein, humanGlial Fibrillary Acidic ProteinInterleukin-6MAPT protein, humanneurofilament protein LNeurofilament ProteinsPeptide Fragmentstau Proteinschronic traumatic encephalopathycollege footballconcussionfootballhead traumaNational Football Leagueneurodegenerative diseaseplasma biomarkersrepetitive head impactssubconcussiontraumatic brain injurytraumatic encephalopathy syndrome

Identifiers

PMID39351900
PMCPMC11567811

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.